PERFIL DE SEGURANÇA APÓS EXPOSIÇÃO À DIFERENTES FORMULAÇÕES DE ANFOTERICINA B EM 1879 PACIENTES COM INFECÇÃO FÚNGICA INVASIVA (IFI): ESTUDO OBSERVACIONAL BRASILEIRO

Marcello Mihailenko Chaves Magri(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Flávio Queiroz‐Telles(Hospital de Clínicas Universidade Federal do Paraná), Diego R. Falci(Hospital de Clínicas de Porto Alegre), Fabianne Carlesse(Support group for adolescents and children with cancer), Carla Sakuma de Oliveira(Hospital Universitário Regional do Norte do Paraná), Giovanni Luís Breda(Radboud University Nijmegen), Hugo Manuel Paz Morales(Hospital Erasto Gaertner), Francelise Bridi Cavassin(Faculdade de Administração Ciências Educação e Letras), Renata de Bastos Ascenço Soares(Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais), José Ernesto Vidal(Universidade de São Paulo), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Cássia Silva de Miranda Godoy(Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais), Fábio de Araújo Motta(Hospital Erasto Gaertner)
The Brazilian Journal of Infectious Diseases
October 1, 2023
10.1016/j.bjid.2023.103311
Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
Chromoblastomycosis
|Clinical Microbiology Reviews|2016|339